2410 — TYK Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.60bn
- HK$4.36bn
- CNY0.11m
Annual cashflow statement for TYK Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -312 | -383 | -388 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 77.1 | 104 | 102 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -1.66 | 51 | -52.1 |
| Change in Accounts Receivable | |||
| Change in Payable / Accrued Expenses | |||
| Net Change in Other Assets & Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -220 | -201 | -308 |
| Capital Expenditures | -88.2 | -77.3 | -73.6 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -70 | 150 | -62.2 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -158 | 73 | -136 |
| Financing Cash Flow Items | 27.8 | 55.5 | -68.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 351 | 224 | 632 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -27.1 | 96.1 | 188 |